If I told you our state-of-the-science review paper on masks (with 400 references) is soon to be published by a leading US journal, what would your reaction be? Emojis and gifs only.

Really these people are the worst kind of trolls.

This is what it took to break the Tavistock story. Bravery.

So do I want to watch the Netflix film Scoop which is supposed to be based on a real life story but is actually a fictionalised account of how one person supposedly landed the Andrew interview which isn’t true?

This is an error, she is pointing to old material, and i understand it is being fixed. But it is an interesting lesson in what can go wrong.

The idea that medication would treat all these vulnerable kids was pushed hard by several activist groups we all know. And this was repeated as gospel by many journalists who should have known better. It’s a sorry story.

The #CassReview is definitive: a whole generation of vulnerable kids has been misled into thinking medical transition is the cure for their various mental health crises.
So the question is, where did this idea come from? Who was pushing it and why?

thetimes.co.uk/article/cass-r…

Asked a while back if reporting on puberty blockers and the Tavistock was difficult. My response: Aside from toxicity and lack of support at times, it wasn’t. I’ve been working in evidence based medicine for 20 years…this was no different. It’s good to see Cass highlight this

Actually there was one person who did do as much, if not more, to break this story… it the journalist on BBC Newsnight — Deborah Cohen 🤦🏻‍♀️

Two BIG job openings at The Economist right now. The first is our Marjorie Deane internship. It's a six month gig in London with our finance and economics section. No previous experience required. Many great colleagues who work at the paper started here. economist.com/finance-and-ec…

View of the eclipse from orbit

The power of Mia® to help doctors find invasive breast cancers earlier is highlighted in The Economist 's latest Tech Quarterly. Special thanks to Natasha Loder 🐋 for covering this important development.

economist.com/technology-qua…

economist.com/finance-and-ec… Want to write about economics for The Economist? No journalism experience necessary but you *do* have to know a lot about economics (sorry)

Changes to the blue tick policy feel sort of inevitable. Plenty of good folks on Twitter who invest in it for reasons of broader public good. They neither want to pay or be paid—but are nonetheless. Also they can hide the folks who just paid to be heard

Hear OHC Director, Matthew Wood, talk on the BBC about the UK Rare Therapies Launch Pad and how we're developing new treatment pathways with MHRAgovuk Genomics England.
Thank you Natasha Loder 🐋 Sandra Kanthal for sharing how Mila's legacy inspires us:
bbc.co.uk/programmes/m00…

How far are we from seeing this happening in our practice?

How do you feel about it?

Credits to Natasha Loder 🐋

“Of the 1,500 vendors in health #AI , over half were founded in the past seven years.” Nice article on the potential of medical #AI in the The Economist today!
buff.ly/4agiWT3

Good feature on #BBCR4 . Goes beyond the usual 'ain't that quaint* science doled out by the media.

Last November I broke this story for The Economist about efforts to create the world's first regulatory pathway for customised medicines -- here in the UK.
At 11am on Radio 4 hear the human story--a new radio documentary with Sandra Kanthal...

economist.com/britain/2023/1…

AIs will make health care safer and better
economist.com/technology-qua… via Natasha Loder 🐋